DRI HEALTHCARE TRUST (DHT-UN.CA) Stock Price, Forecast & Analysis

TSX:DHT-UN • CA23344H1091

15.84 CAD
0 (0%)
Last: Feb 12, 2026, 07:00 PM
Overview Stock Chart Technical Analysis News

DHT-UN.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap872.94M
Revenue(TTM)192.69M
Net Income(TTM)-52.23M
Shares55.11M
Float54.60M
52 Week High17.31
52 Week Low10.7
Yearly DividendN/A
Dividend Yield4.57%
EPS(TTM)2.25
PE7.04
Fwd PE6.9
Earnings (Next)03-02
IPO2021-02-11
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
DHT-UN.CA short term performance overview.The bars show the price performance of DHT-UN.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 4 6 8 10

DHT-UN.CA long term performance overview.The bars show the price performance of DHT-UN.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of DHT-UN.CA is 15.84 CAD. In the past year, price increased by 34.12%.

DRI HEALTHCARE TRUST / DHT-UN Daily stock chart

DHT-UN.CA Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to DHT-UN.CA. When comparing the yearly performance of all stocks, DHT-UN.CA turns out to be only a medium performer in the overall market: it outperformed 60.68% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
DHT-UN.CA Full Technical Analysis Report

DHT-UN.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
BHC BAUSCH HEALTH COS INC1.372.952B
GSD DEVONIAN HEALTH GROUP INC N/A1.991B
CRON CRONOS GROUP INC36.31.348B
TLRY TILRAY BRANDS INC N/A1.179B
GUD KNIGHT THERAPEUTICS INC124.44592.761M
WEED CANOPY GROWTH CORP N/A526.898M
NGEN NERVGEN PHARMA CORP N/A411.936M
CPH CIPHER PHARMACEUTICALS INC26.54360.254M
TSND TERRASCEND CORP N/A287.235M

Related stock screener links

View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges

DRI HEALTHCARE TRUST / DHT-UN.CA FAQ

What does DRI HEALTHCARE TRUST do?

DRI Healthcare Trust is an unincorporated open-ended company. The company is headquartered in Toronto, Ontario and currently employs 36 full-time employees. The company went IPO on 2021-02-11. The firm provides capital to universities and research institutions, academic institutions, biotechnology companies and pharmaceutical companies. The company has acquired more than 75 royalties on 45-plus drugs, including Ekterly, Eylea, Keytruda, Orserdu, Remicade, Spinraza, Stelara, Vonjo and Zytiga. Its portfolio includes Empaveli/Syfovre, Eylea I, Eylea II, Natpara, Omidria, Oracea, Orserdu I, Orserdu II, Rydapt, Vonjo I, Vonjo II, Xenpozyme, Xolair, Zejula, and other products. Its therapeutic areas include oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, lysosomal storage disorders (LSD) and immunology. The Company’s products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; Vertex Pharmaceuticals; KalVista, Galderma and others.


What is the stock price of DRI HEALTHCARE TRUST today?

The current stock price of DHT-UN.CA is 15.84 CAD.


What is the ChartMill rating of DRI HEALTHCARE TRUST stock?

DHT-UN.CA has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 4 out of 10.